The risk of NAFLD is positively associated with elevations in both insulin-based and non-insulin-based IR markers, including HOMA-IR, TyG, TyG-BMI, TG/HDL-c, and METS-IR in non-diabetic population. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.